Titelia

Holdings of Franklin Genomic Advancements ETF

Franklin Templeton ETF Trust · 58 declared positions · as of Mar 31, 2026

Original filing · Net assets 21.4M $ · Ten largest lines: 47 % of the equity sleeve

Sector breakdown

  • Health care 17.0 %
  • Materials 2.8 %
  • Technology 0.7 %
  • Unattributed 79.4 %

Sector is not declared in Form N-PORT: this is a Titelia classification, decided company by company. The unattributed share is counted as such rather than spread over the others.

Currency breakdown

  • USD 94.7 %
  • KRW 3.7 %
  • EUR 1.6 %

The currency each line is denominated in, as declared. It does not follow the country: a French company listed in the United States is declared in dollars.

Country breakdown

  • US 87.3 %
  • KR 3.7 %
  • GB 3.5 %
  • DE 1.9 %
  • BE 1.6 %
  • CH 1.1 %
  • IE 0.8 %
  • SG 0.2 %

Shares computed on the equity sleeve, the only part this site carries.

CountryLinesValueShare
US5018M $87.33 %
KR2753.1K $3.66 %
GB1728.7K $3.54 %
DE1385.7K $1.87 %
BE1328.3K $1.59 %
CH1222.2K $1.08 %
IE1159K $0.77 %
SG132.4K $0.16 %

Positions

CompanySharesValueWeight
Guardant Health Inc 15,7181.5M $6.77 %
Natera Inc 7,1311.4M $6.65 %
Krystal Biotech Inc 4,4181.1M $5.32 %
United Therapeutics Corp 1,680996.2K $4.65 %
Insmed Inc 5,932970K $4.52 %
Bridgebio Pharma Inc 12,192905.4K $4.22 %
Ligand Pharmaceuticals Inc 3,794757.5K $3.53 %
AstraZeneca PLC 3,695728.7K $3.40 %
Adaptive Biotechnologies Corp 48,245669.6K $3.12 %
Vertex Pharmaceuticals Inc 1,435640.8K $2.99 %
Samsung Biologics Co Ltd 652640.2K $2.99 %
Medpace Holdings Inc 1,327637.2K $2.97 %
Regeneron Pharmaceuticals, Inc. 748577.9K $2.69 %
Corteva Inc 6,904577.9K $2.69 %
Alnylam Pharmaceuticals Inc 1,687558.2K $2.60 %
Eli Lilly & Co 593545.4K $2.54 %
Ionis Pharmaceuticals Inc 5,957447.3K $2.09 %
Tempus AI Inc 8,726394.6K $1.84 %
BioNTech SE 4,340385.7K $1.80 %
Neurocrine Biosciences Inc 2,693354.8K $1.65 %
Stoke Therapeutics Inc 10,539343.1K $1.60 %
Twist Bioscience Corp 7,184341.4K $1.59 %
Argenx SE 459328.3K $1.53 %
PTC Therapeutics Inc 4,652316.9K $1.48 %
Travere Therapeutics Inc 10,129300.9K $1.40 %
Charles River Laboratories International Inc 1,445249.3K $1.16 %
CRISPR Therapeutics AG 4,671222.2K $1.04 %
Repligen Corp 1,866219.9K $1.03 %
Veracyte Inc 6,788218.6K $1.02 %
Praxis Precision Medicines Inc 667214.9K $1.00 %
GRAIL Inc 4,138213.9K $1.00 %
Danaher Corp 1,050199.1K $0.93 %
Thermo Fisher Scientific Inc 391192.2K $0.90 %
IQVIA Holdings Inc 1,005171.4K $0.80 %
Beam Therapeutics Inc 7,036167.7K $0.78 %
Jazz Pharmaceuticals PLC 841159K $0.74 %
Catalyst Pharmaceuticals Inc 6,375157.8K $0.74 %
Cadence Design Systems Inc 545151.4K $0.71 %
Agilent Technologies Inc 1,136129.5K $0.60 %
CareDx Inc 7,429129K $0.60 %
QIAGEN NV 3,175127.1K $0.59 %
AnaptysBio Inc 2,041113.2K $0.53 %
Samsung Episholdings Co Ltd 350112.9K $0.53 %
Tarsus Pharmaceuticals Inc 1,487104.3K $0.49 %
Ultragenyx Pharmaceutical Inc 4,76599.8K $0.47 %
Arcutis Biotherapeutics Inc 4,10796.8K $0.45 %
Axsome Therapeutics Inc 56695.7K $0.45 %
GeneDx Holdings Corp 1,40990.5K $0.42 %
Rhythm Pharmaceuticals Inc 97484.7K $0.40 %
Hinge Health Inc 2,18284.1K $0.39 %
Bristol-Myers Squibb Co 1,11167.4K $0.31 %
Bio-Rad Laboratories Inc 22663K $0.29 %
BEONE MEDICINES LTD 20962.1K $0.29 %
TransMedics Group Inc 48247.9K $0.22 %
Neurogene Inc 1,84037.1K $0.17 %
WaVe Life Sciences Ltd 4,47032.4K $0.15 %
Recursion Pharmaceuticals Inc 10,39331.9K $0.15 %
Caris Life Sciences Inc 55710K $0.05 %